Skip to main content
PAS 2025 Meeting Main banner
Final Program


Schedule at a Glance
Icon Legend
Presentation Icons
Ticketed Event
Ticketed Event
Norman J. Siegel New Member Outstanding Science Award
Norman J. Siegel New Member Outstanding Science Award
John Howland Award
John Howland Award
Mary Ellen Avery Award
Mary Ellen Avery Award
SPR Thomas A. Hazinski Distinguished Service Award
SPR Thomas A. Hazinski Distinguished Service Award
SPR Douglas K. Richardson Award for Perinatal and Pediatric Healthcare Research
SPR Douglas K. Richardson Award for Perinatal and Pediatric Healthcare Research
PROSPER Diversity Award
PROSPER Diversity Award
ASPN Founders’ Award
ASPN Founders’ Award
David G. Nichols Health Equity Award
David G. Nichols Health Equity Award
ASPN Mid-Career Award
ASPN Mid-Career Award
Awarded Part 4 Maintenance of Certification (MOC) Credit
Awarded Part 4 Maintenance of Certification (MOC) Credit
Poster Icons
Awarded Part 4 Maintenance of Certification (MOC) Credit
Awarded Part 4 Maintenance of Certification (MOC) Credit
ViewAttendees 73

Neonatal Clinical Trials

Neonatology

Neonatal Clinical Trials 2

The Budesonide in Babies (BiB) Trial

Monday, April 28, 2025
9:45am – 10:00am HST
Location:  Convention Center: Kalākaua Ballroom A (Level 4)
Publication Number: 4135.3
Namasivayam Ambalavanan, University of Alabama School of Medicine, Birmingham, AL, United States; NICHD Neonatal Research Network, National Institute of Child Health and Human Development, Bethesda, MD, United States

    Presenting Author(s)

  • Namasivayam Ambalavanan, MD (he/him/his)

    Professor of Pediatrics
    University of Alabama School of Medicine
    Birmingham, Alabama, United States

    Slides Video
Disclosure(s):
Namasivayam Ambalavanan, MD: AlveolusBio (Ongoing) (Products/Services: Advisory Committee, Intellectual Property including patent beneficiary and royalties, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Oak Hill Bio (Ongoing) (Products/Services: Consultant); ResBiotic (Ongoing) (Products/Services: Advisory Committee, Intellectual Property including patent beneficiary and royalties, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)